ConductScience.org, home

Gene · 2243

Papers3,650

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Deep cervical lymphatic-venous anastomosis attenuates cognitive dysfunction and biomarker abnormalities in severe Alzheimer's disease: A prospective single-arm study.Alzheimers Dement202641630624PubTator, text miningPubMed
Sex-specific cardioprotective role of miR-30a-5p through estrogen-dependent mechanisms in a mouse model of heart failure.Cardiovasc Diabetol202641612389PubTator, text miningPubMed
Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma.J Immunother Cancer202641592893PubTator, text miningPubMed
Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis.Transl Oncol202641547146PubTator, text miningPubMed
Elucidating the mechanism of fulvic acid-mediated PCR inhibition and its mitigation through nanoparticle-assisted amplification.Forensic Sci Int202641546941PubTator, text miningPubMed
The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction.Respir Res202641540423PubTator, text miningPubMed
Divergent evolution of hepatocellular carcinoma genomes in chimpanzees and humans.Evol Med Public Health202641522204PubTator, text miningPubMed
FGA Serves as a Potential Diagnostic Marker and Therapeutic Target for Elderly Acute Kidney Injury.J Proteome Res202641512179PubTator, text miningPubMed
Single-cell transcriptome sequencing reveals hepatocyte heterogeneity in response to radiation-induced liver injury and regeneration.Radiother Oncol202641429723PubTator, text miningPubMed
Post-Transcriptional Modification Integration for Ligand-Receptor Cellular Network Inference.Mol Cell Proteomics202641423050PubTator, text miningPubMed
Comparative proteomic profiling of advanced, injectable, and titanium-prepared platelet rich fibrins (PRF): Insights into functional divergence and clinical potential.Biochim Biophys Acta Proteins Proteom202641419009PubTator, text miningPubMed
Novel and known fibrinogen gene mutations in Chinese pediatric patients with congenital dysfibrinogenemia: genetic and functional characterization.Clin Biochem202641344552PubTator, text miningPubMed
Genetic Characterization of Congenital Fibrinogen Disorders: A Retrospective Analysis of 102 Unrelated Patients in China.Semin Thromb Hemost202641297894PubTator, text miningPubMed
Congenital hypofibrinogenemia with bleeding risk: mutations in the FGA, FGB, and FGG genes.Lab Med202641233956PubTator, text miningPubMed
CRISPR-Cas9-Targeted Nanopore Sequencing for STR Typing.Electrophoresis202641194485PubTator, text miningPubMed
Linking STRs/SNPs and DNA methylation using massively parallel sequencing for potential forensic applications.Int J Legal Med202641116011PubTator, text miningPubMed
Data-independent acquisition-mass spectrometry proteomic analysis reveals fibrinogen α, β, and γ chains as candidate biomarkers for the nonmaturation of autogenous arteriovenous fistula.Int Urol Nephrol202640999258PubTator, text miningPubMed
Genetic mutations associated with congenital fibrinogen disorders: global distribution and clinical outcomes.J Thromb Thrombolysis202640879865PubTator, text miningPubMed
Correlation analysis between plasma circulating tumour deoxyribonucleic acid variations and survival in patients with hepatocellular carcinoma.Front Oncol202541743182PubTator, text miningPubMed
Exploratory Urinary Proteomic Profiling in Pregnancies with Fetal Aneuploidies: Molecular Insights into Maternal-Fetal Metabolic Communication.Curr Issues Mol Biol202541614738PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2243/papers?page=3